Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current Evidence
Biosimilar medicines: what are they and how are they used?
Plain Language Summary
Provider and Patient Knowledge Gaps on Biosimilars: Insights From Surveys
What do patients and health care providers still need to know about biosimilar medicines?
eAppendix: Provider and Patient Knowledge Gaps on Biosimilars: Insights From Surveys
Biosimilars for Immune-Mediated Inflammatory Diseases – A Managed Care Perspective
What are the current challenges to wider biosimilar use in the United States?
Current Therapeutic Agents and Treatment Paradigms for the Management of Rheumatoid Arthritis
Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid Arthritis: A Synopsis
Overview of Epidemiology, Pathophysiology, and Diagnosis of Rheumatoid Arthritis
Comparative Effectiveness of Current Treatments for Rheumatoid Arthritis